Development of anti-influenza A compounds: a pilot study

Area of Science:

• Virology
• Medicinal Chemistry
• Pharmacology

Background:

• H5N1 avian influenza poses a significant threat due to the lack of effective antiviral agents.
• Chemical compounds containing halogenated benzoyl residues have demonstrated potential in inhibiting viral infections.
• BFDBSC is a known compound that can inhibit H5N1 virus infection in cell cultures.

Purpose of the Study:

• To evaluate the anti-H5N1 activity and toxicity of four novel chemical compounds featuring halogenated benzoyl residues.
• To identify specific structural features contributing to antiviral efficacy against H5N1.
• To assess the preliminary safety profile of these compounds in a cell culture system.

Main Methods:

• Pilot study utilizing a cell culture system to assess antiviral activity.
• Synthesis and screening of four chemical compounds: FPBFDBSC, BFB-gallate, BFB-borneol, and BFB-menthol.
• Evaluation of compound toxicity at tested concentrations.

Main Results:

• Two compounds, FPBFDBSC and BFB-gallate, exhibited superior anti-H5N1 activity compared to the reference compound BFDBSC.
• BFB-borneol and BFB-menthol displayed lower antiviral effects than BFDBSC.
• None of the tested compounds demonstrated significant toxicity in the cell culture model.

Conclusions:

• Halogenated benzoyl residues appear to be crucial for the observed anti-H5N1 effects.
• FPBFDBSC and BFB-gallate represent promising candidates for further development as anti-H5N1 agents.
• Poor aqueous solubility of these compounds may present a challenge for their clinical application.